Amcor shares (ASX:AMC) have rallied 25% over the past seven weeks, building momentum after a difficult start to the year that had seen holders nursing losses of 18% YTD into mid May. The latest close at A$64.27 continues a post-integration rally that has now pushed the packaging giant’s technical indicators deep into overbought territory with an RSI ~75.
The rally in Amcor shares appears to reflect continued confidence in the company’s ability to extract value from its transformational Berry Global acquisition. Markets appear willing to lean into the scale and synergy narrative even as the stock’s pushes the RSI into levels that can signal near-term exhaustion and heightened vulnerability to profit-taking.
The most recent major catalyst remains Amcor’s third-quarter update in early May, when management reaffirmed full-year guidance and highlighted 77 million dollars in acquisition synergies already delivered. The company maintained its fiscal 2026 adjusted earnings-per-share guidance of 3.98 to 4.03 dollars and free cash flow expectations of 1.5 to 1.6 billion dollars, despite acknowledging a challenging volume backdrop across key end markets. That combination of cost discipline, margin improvement, and guidance confidence appears to have given momentum buyers permission to push the stock higher, even as the underlying volume picture remains soft.
The integration story has been reinforced by management’s execution language and by insider confidence, with the chief financial officer making open-market purchases in recent months. The market has been willing to tolerate a premium valuation on the view that Amcor has emerged from the Berry deal as a larger, more resilient packaging platform with improved pricing power and a clearer path to deleveraging. The company completed a one-for-five reverse stock split in January, a technical adjustment that has not altered the fundamental debate but may have contributed to improved trading liquidity and institutional appetite.
View From The Street
Consensus among analysts points to a target price of 73.16 dollars, implying roughly 12.9% upside from current levels. That gap suggests the Street still sees value in the integration thesis and believes the stock can work higher as synergies compound and leverage declines. However, the target also complicates today’s action: with the stock already extended on momentum and trading at a premium to packaging peers on earnings metrics, the market may need a fresh catalyst or a sustained improvement in volume trends to justify chasing it much higher from here. The valuation debate remains live, with much of the bull case tied to future execution rather than current fundamentals.
Top Australian Brokers
- Pepperstone - Top Australian broker - Read our review
- eToro - Invest in ASX and international shares - Read our review
What Lay Ahead
The stock’s position above both its 50-day and 200-day moving averages confirms the medium-term uptrend remains intact, but the overbought RSI reading suggests the share price may be getting ahead of near-term fundamentals.
The technical setup is strong from a trend perspective, yet vulnerable to an air pocket if buyers step back or if the company stumbles on integration, cash conversion, or guidance in the quarters ahead.
Any stumble in integration, cash conversion, or guidance could trigger quick profit-taking from a technically stretched base. Conversely, a sustained improvement in volume trends or an acceleration in synergy capture could justify the current valuation and pull the stock toward the Street’s target. For now, the market is betting on execution and willing to pay up for scale, but the overbought technical setup suggests caution is warranted in the near term.
Bull Case:
- 77 million dollars in synergies delivered, with more to come as integration progresses.
- Guidance reaffirmed despite soft volumes, signaling margin resilience and cost discipline.
- Consensus target implies 12.9% upside, supporting the rerating thesis.
Bear Case:
- Overbought RSI signals near-term exhaustion and profit-taking risk.
- Volume weakness persists across key end markets, pressuring top-line growth.
- Elevated leverage after Berry deal leaves little room for execution missteps.